MedTrace Logo

Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder

NCT03806946 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-04-14

No results posted yet for this study

Summary

The most common neuropsychiatric disorder in early childhood is attention deficit/hyperactivity disorder (ADHD) with evidence of abnormality in structure and function of brain. Epilepsy is one of the commonest comorbidity associated with ADHD with negative outcome on childrens' quality of life, and is considered to be a risk for academic underachievement. These two disorders are highly associated, with more possibility to be a bidirectional relationship. The mechanisms of this comorbidity are unknown. In this association, a difficult challenge is presented since antiepileptic therapy and drugs used to treat ADHD may aggravate the clinical picture of each other. The main objectives are to evaluate this overlap of those disorders, find their complications on child and his family, and to suggest possible solutions to improve the outcome of those children.

Conditions

  • Attention-Deficit Hyperactivity Disorder
  • Epilepsy

Interventions

DIAGNOSTIC_TEST

electroencephalography

diagnosis epileptic discharge

DIAGNOSTIC_TEST

psychometric scales to diagnosis psychiatric disorders

to diagnosis intellectual disability, attention deficit hyperactivity disorder ,epilepsy,autism and other mental illness.

OTHER

psychometric scales for assesment socioeconomic and behaviour problems

to assessment other behavioural comorbidity as aggression ,mood changes,etc and help in identify function impairment, social and economic burden

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Alaa El-Din Darweesh, PhD · Assiut University

  • HossamEddin Ahmad, PhD · Assiut University

  • Patrick Bolton, PhD · King's College London

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-15
Primary Completion
2019-12-30
Completion
2020-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03806946 on ClinicalTrials.gov